#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pulmonary fibrosis Haemophilia Cushing's syndrome Dementia Alzheimer's type Blastic plasmacytoid dendritic cell neoplasia Squamous cell carcinoma of head and neck Hypersomnia Myelodysplastic syndrome with excess blasts Systemic mastocytosis Small cell lung cancer extensive stage Thrombocytosis Ewing's sarcoma recurrent Indolent systemic mastocytosis Anti-HLA antibody test positive Hereditary neuropathic amyloidosis More trials…

    Learn about Rare Diseases

    Cerebral arteriovenous malformation haemorrhagic – Life with Disease Wiskott-Aldrich syndrome – Trials in Disease Marginal zone lymphoma Optic glioma – Life with Disease Shprintzen-Goldberg syndrome – Life with Disease Glycogen storage disease type II – Treatment Proteus syndrome Retinoblastoma – Diagnostics Bronchiolitis obliterans syndrome – Diagnostics Phenylketonuria – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SGT-003 Hexaminolevulinate Micafungin Litenimod Sodium PAPAVERINE HYDROCHLORIDE Colecalciferol Etamsylate Tofersen Sulfamethizole Ecopipam Hydrochloride TRONTINEMAB Betamethasone Valerate VELPATASVIR Methylone Alkaline Phosphatase, Bovine Cemiplimab Daridorexant METAMIZOLE SODIUM Briquilimab Islatravir More therapies…

    Learn about Your Condition

    Mitral valve incompetence Solitary fibrous tumour Adenosquamous cell lung cancer Varices oesophageal Non-small cell lung cancer Neurodegenerative disorder Chronic hepatitis C Procedural pain Triple negative breast cancer Abdominal infection Penile squamous cell carcinoma Lupus nephritis Dementia Alzheimer's type Weaning failure Skin bacterial infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Systemic scleroderma

  • Study of Blinatumomab Treatment in Patients with Systemic Lupus Erythematosus, Systemic Sclerosis, or Granulomatosis with Polyangiitis: Safety and Effectiveness Evaluation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Granulomatosis with polyangiitis
    • Systemic scleroderma
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Blinatumomab
    Germany

  • Study on the Effects and Safety of Rituximab and Sodium Chloride in Patients with Active Systemic Sclerosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Rituximab
    • Sodium Chloride
    The Netherlands

  • Study on the Safety of CNTY-101 and Aldesleukin for Patients with Active Autoimmune Diseases: Lupus, Scleroderma, and Myositis

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Idiopathic inflammatory myopathy
    • Systemic scleroderma
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Aldesleukin
    Germany

  • Study on the Effectiveness and Safety of Efgartigimod PH20 SC for Adults with Systemic Sclerosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Efgartigimod Alfa
    Belgium Bulgaria Croatia Czechia Denmark France +10

  • Study on the Safety of T-Guard (Dafsolimab Setaritox, Grisnilimab Setaritox) for Patients with Early Diffuse Cutaneous Systemic Sclerosis

    Recruiting

    1 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • GRISNILIMAB SETARITOX
    The Netherlands

  • Study on the Effectiveness and Safety of Ianalumab for Patients with Diffuse Cutaneous Systemic Sclerosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Entecavir
    • Ianalumab
    • Tenofovir Disoproxil
    Austria Belgium France Germany Greece Hungary +4
Previous Page
1 2 3 4 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!